Considering the fact that berberine significantly attenuates the production of IL-18 and IL-1β, which are normally highly expressed in gliomas, we questioned if berberine treatment would significantly decrease the viability of glioma cells. This evidence concerns the gene IL1B and central nervous system cancer.